Abstract:Objectives In the study, we hypothesised menstrual blood stem cells (MBSCs) protect ischaemic myocardium through paracrine effect. Methods MBSCs were isolated and expanded from human female menstrual blood. Then we infused the MBSCs intramyocardially in a rat acute myocardial infarction model, and cocultured MBSCs with neonatal rat cardiomyocytes (NRCs). Results In vitro experiments, the apoptosis ratio of NRCs underwent hypoxia/reoxygenation in coculture group was lower than the control group (8.95±1.32% vs 18.42±1.80%, p<0.01), and intracellular ROS generation was also lower (change fold, 27.8±4.1% vs 80.0±12.7%, p<0.01). The medium of normoxia and hypoxia cultured MBSCs was determined the secreted EGF, VEGF and TGF-β (559±21, 0, 635±59 ng/ml in normoxia culture respectively, 582±19, 198±6, 664±102 ng/ml in hypoxia culture respectively). The RNA was also extracted and reverse transcriptional PCR showed that MBSCs expressed multiple cytokines. The MBSCs were transplanted intramyocardially after ligation of the left anterior descending (LAD) in rats. After 48 h, less apoptotic cardiomyocytes were detected in the transplant group (infarct, 54.24±2.10% vs 67.97±3.28%, p<0.01; peri-infarct, 6.93±1.05% vs 11.88±1.47%, p<0.05) and western blot showed higher level of AKT phosphorylation and upregulation of BAX, as well as the decreased expression of cleaved caspase 9. 4 weeks later, 18-fluorodeoxyglucose microPET images indicated more viable cardiomyocytes in the scar area of transplant group than those of saline group (0.357±0.067 vs 0.275±0.053, p<0.01 in transverse section, 0.333±0.046 vs 0.267±0.045, p<0.01 in coronal section). The infarct size of transplant group was less than saline group in Masson9s trichrome stain (33.6±2.9% vs 41.6±4.9%, p<0.05). Immunofluorescence of the peri-infarct and infarct region by vWF and α-SMA staining showed obviously higher vessel density in the transplant group (vWF positive microvessels, 186±16/field vs 118±12/field, p<0.05; α-SMA positive arteriole, 35±7/field vs 21±6/field, p<0.05). Few differentiation of MBSCs toward endotheliocyte, smooth muscle cell and cardiomyocytes were found and no specific immune cell infiltration were observed around the MBSCs in vivo. Conclusions MBSCs paracrined multiple cytokines to protect cardiomyocytes from apoptosis and stimulate angiogenesis, which rescued the myocardium in the infarct region and finally resulted in a better cardiac function.

Extracellular vesicles derived from human bone marrow mesenchymal stem cells protect rats against acute myocardial infarction-induced heart failure

Extracellular vesicles derived from myocardial infarction plasma inhibit BMSCs apoptosis and enhance cardiac function via AKT signaling pathway

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

HIF-1α overexpression in mesenchymal stem cell-derived exosome-encapsulated arginine-glycine-aspartate (RGD) hydrogels boost therapeutic efficacy of cardiac repair after myocardial infarction

Menstrual Blood Stem Cells Attenuate Post-Infarction Myocardial Fibrosis Via Inhibiting Endothelial to Mesenchymal Transition (Endmt)

MENSTRUAL BLOOD STEM CELLS IMPROVED MYOCARDIAL SURVIVAL AFTER RAT MYOCARDIAL INFARCTION BY PARACRINE

Myocardin-Related Transcription Factor-A-Overexpressing Bone Marrow Stem Cells Protect Cardiomyocytes And Alleviate Cardiac Damage In A Rat Model Of Acute Myocardial Infarction

Bone marrow mesenchymal stem cells improve cardiomyocyte contractility in rats with heart failure

Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction

Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction

Effects of Hepatocyte Growth Factor Overexpressed Bone Marrow‐derived Mesenchymal Stem Cells on Prevention from Left Ventricular Remodelling and Functional Improvement in Infarcted Rat Hearts

Cellular Repressor of E1A-stimulated Gene Overexpression in Bone Mesenchymal Stem Cells Protects Against Rat Myocardial Infarction.

Autologous Extracellular Vesicles Attenuate Cardiac Injury in Experimental Atherosclerotic Renovascular Disease More Effectively Than Their Parent Mesenchymal Stem/Stromal Cells

Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction

In Vitro and in Vivo Effects of Bone Marrow Stem Cells on Cardiac Structure and Function

Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Alleviate Renal Ischemic Reperfusion Injury and Enhance Angiogenesis in Rats.

HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia.

HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis

Intravenous Infusion Of Bone Marrow Mesenchymal Stem Cells Improves Myocardial Function In A Rat Model Of Myocardial Ischemia

Astragaloside IV induces the protective effect of bone marrow mesenchymal stem cells derived exosomes in acute myocardial infarction by inducing angiogenesis and inhibiting apoptosis.

Atorvastatin Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Acute Myocardial Infarction Via Up-Regulating Long Non-Coding RNA H19